{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:18:59Z","timestamp":1786979939629,"version":"build-2736575974"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2011,5,8]],"date-time":"2011-05-08T00:00:00Z","timestamp":1304812800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Chemother Pharmacol"],"published-print":{"date-parts":[[2011,9]]},"DOI":"10.1007\/s00280-011-1666-0","type":"journal-article","created":{"date-parts":[[2011,5,7]],"date-time":"2011-05-07T05:11:51Z","timestamp":1304745111000},"page":"823-826","source":"Crossref","is-referenced-by-count":40,"title":["5-FU-induced neurotoxicity in cancer patients with profound DPD deficiency syndrome: a report of two cases"],"prefix":"10.1007","volume":"68","author":[{"given":"Pierre-Yves","family":"Cordier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9","family":"Nau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Ciccolini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuela","family":"Oliver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9dric","family":"Mercier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Lacarelle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Peytel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,5,8]]},"reference":[{"issue":"1","key":"1666_CR1","first-page":"103","volume":"26","author":"M Tsalic","year":"2003","unstructured":"Tsalic M, Bar-Sela G, Beny A, Visel B, Haim N (2003) Severe toxicity related to the 5-fluorouracil\/leucovorin combination (the Mayo Clinic regimen): a prospective study in colorectal cancer patients. Am J Clin Oncol 26(1):103\u2013106","journal-title":"Am J Clin Oncol"},{"issue":"4","key":"1666_CR2","doi-asserted-by":"crossref","first-page":"288","DOI":"10.3816\/CCC.2006.n.047","volume":"6","author":"C Mercier","year":"2006","unstructured":"Mercier C, Ciccolini J (2006) Profiling dihydropyrimidine dehydrogenase deficiency in patients with cancer undergoing 5-fluorouracil\/capecitabine therapy. Clin Colorectal Cancer 6(4):288\u2013296","journal-title":"Clin Colorectal Cancer"},{"issue":"8","key":"1666_CR3","first-page":"527","volume":"2","author":"A Lee","year":"2004","unstructured":"Lee A, Ezzeldin H, Fourie J, Diasio R (2004) Dihydropyrimidine dehydrogenase deficiency: impact of pharmacogenetics on 5-fluorouracil therapy. Clin Adv Hematol Oncol 2(8):527\u2013532","journal-title":"Clin Adv Hematol Oncol"},{"issue":"2","key":"1666_CR4","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1080\/07357900500524702","volume":"24","author":"ABP Kuilenburg van","year":"2006","unstructured":"van Kuilenburg ABP (2006) Screening for dihydropyrimidine dehydrogenase deficiency: to do or not to do, that\u2019s the question. Cancer Invest 24(2):215\u2013217","journal-title":"Cancer Invest"},{"issue":"5","key":"1666_CR5","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1097\/01.ftd.0000245771.82720.c7","volume":"28","author":"J Ciccolini","year":"2006","unstructured":"Ciccolini J, Mercier C, Evrard A, Dahan L, Boyer J-C, Duffaud F, Richard K, Blanquicett C, Milano G, Blesius A, Durand A, Seitz J-F, Favre R, Lacarelle B (2006) A rapid and inexpensive method for anticipating severe toxicity to fluorouracil and fluorouracil-based chemotherapy. Ther Drug Monit 28(5):678\u2013685","journal-title":"Ther Drug Monit"},{"issue":"12","key":"1666_CR6","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/j.revmed.2005.02.008","volume":"26","author":"L Guilloton","year":"2005","unstructured":"Guilloton L, Michaud A, Potier V, Le Berre J, Drouet A, Felten D (2005) Ataxia and confusion after treatment with 5 Fluorouracile. Rev Med Interne 26(12):986\u2013987","journal-title":"Rev Med Interne"},{"issue":"4","key":"1666_CR7","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1159\/000320032","volume":"56","author":"S-R Kim","year":"2010","unstructured":"Kim S-R, Park C-H, Park S, Park J-O, Lee J, Lee S-Y (2010) Genetic polymorphisms associated with 5-Fluorouracil-induced neurotoxicity. Chemotherapy 56(4):313\u2013317","journal-title":"Chemotherapy"},{"issue":"3","key":"1666_CR8","first-page":"477","volume":"2","author":"CH Takimoto","year":"1996","unstructured":"Takimoto CH, Lu ZH, Zhang R, Liang MD, Larson LV, Cantilena LR, Grem JL, Allegra CJ, Diasio RB, Chu E (1996) Severe neurotoxicity following 5-fluorouracil-based chemotherapy in a patient with dihydropyrimidine dehydrogenase deficiency. Clin Cancer Res 2(3):477\u2013481","journal-title":"Clin Cancer Res"},{"issue":"1","key":"1666_CR9","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1093\/jnci\/87.1.56","volume":"87","author":"NJ Meropol","year":"1995","unstructured":"Meropol NJ, Creaven PJ, Petrelli NJ, White RM, Arbuck SG (1995) Seizures associated with leucovorin administration in cancer patients. J Natl Cancer Inst 87(1):56\u201358","journal-title":"J Natl Cancer Inst"},{"issue":"8","key":"1666_CR10","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/0014-2964(80)90251-0","volume":"16","author":"M Aksoy","year":"1980","unstructured":"Aksoy M, Basu TK, Brient J, Dickerson JW (1980) Thiamin status of patients treated with drug combinations containing 5-fluorouracil. Eur J Cancer 16(8):1041\u20131045","journal-title":"Eur J Cancer"},{"issue":"2","key":"1666_CR11","doi-asserted-by":"crossref","first-page":"118","DOI":"10.4143\/crt.2010.42.2.118","volume":"42","author":"KA Kwon","year":"2010","unstructured":"Kwon KA, Kwon H-C, Kim MC, Kim S-H, Oh SY, Lee S, Kim H-J (2010) A case of 5-Fluorouracil induced encephalopathy. Cancer Res Treat 42(2):118\u2013120","journal-title":"Cancer Res Treat"},{"issue":"4","key":"1666_CR12","doi-asserted-by":"crossref","first-page":"747","DOI":"10.3346\/jkms.2009.24.4.747","volume":"24","author":"IJ Cho","year":"2009","unstructured":"Cho IJ, Chang HJ, Lee KE, Won HS, Choi MY, Nam EM, Mun Y-C, Lee SN, Seong C-M (2009) A case of Wernicke\u2019s encephalopathy following fluorouracil-based chemotherapy. J Korean Med Sci 24(4):747\u2013750","journal-title":"J Korean Med Sci"},{"issue":"1","key":"1666_CR13","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s00280-010-1282-4","volume":"67","author":"CG Yang","year":"2011","unstructured":"Yang CG, Ciccolini J, Blesius A, Dahan L, Bagarry-Liegey D, Brunet C, Varoquaux A, Frances N, Marouani H, Giovanni A, Ferri-Dessens R-M, Chefrour M, Favre R, Duffaud F, Seitz J-F, Zanaret M, Lacarelle B, Mercier C (2011) DPD-based adaptive dosing of 5-FU in patients with head and neck cancer: impact on treatment efficacy and toxicity. Cancer Chemother Pharmacol 67(1):49\u201356","journal-title":"Cancer Chemother Pharmacol"},{"issue":"4","key":"1666_CR14","doi-asserted-by":"crossref","first-page":"224","DOI":"10.3816\/CCC.2010.n.033","volume":"9","author":"J Ciccolini","year":"2010","unstructured":"Ciccolini J, Gross E, Dahan L, Lacarelle B, Mercier C (2010) Routine dihydropyrimidine dehydrogenase testing for anticipating 5-fluorouracil-related severe toxicities: hype or hope? Clin Colorectal Cancer 9(4):224\u2013228","journal-title":"Clin Colorectal Cancer"}],"container-title":["Cancer Chemotherapy and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-011-1666-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00280-011-1666-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-011-1666-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T06:11:15Z","timestamp":1559023875000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00280-011-1666-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5,8]]},"references-count":14,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,9]]}},"alternative-id":["1666"],"URL":"https:\/\/doi.org\/10.1007\/s00280-011-1666-0","relation":{},"ISSN":["0344-5704","1432-0843"],"issn-type":[{"value":"0344-5704","type":"print"},{"value":"1432-0843","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,5,8]]}}}